|
Notice:
|
|
Suspension of shipments during Golden Week Holidays: From 29 April to 13 May, deadline 16 April.
|
|
| NIG-RNAi Strains Detail |
| Request : Click the "Order" button to request for this stock |
|
| Stock Detail (Last Update: November 2007_FlyBase version FB2007_11) |
| Stock ID |
2286R-2 |
| Symbol |
ND75 |
Full Name |
NADH:ubiquinone reductase 75kD subunit precursor |
| CG No |
CG2286 |
Old CG No |
CG2286 |
| Synonyms |
CG2286, ND75 |
| Accession No (Link to NCBI) |
NM_078528.1 |
| Inserted Chr. |
lll |
| Insertional Mutation |
|
| Phenotype induced by Act5C-GAL4 at 28 degrees |
lethal |
| Map Viewer |
|
Reference
[Please submit your publication]
|
Chew LY, Zhang H, He J, Yu F.<br> The Nrf2-Keap1 pathway is activated by steroid hormone signaling to govern neuronal remodeling.<br> Cell Rep (2021) 36(5) 109466
[
PubMed ID = 34348164
]
[
RRC reference
]
Tan SWS, Yip GW, Suda T, Baeg GH.<br> Small Maf functions in the maintenance of germline stem cells in the Drosophila testis.<br> Redox Biol (2018) 15 125-134
[
PubMed ID = 29245136
]
[
RRC reference
]
Tan SWS, Lee QY, Wong BSE, Cai Y, Baeg GH.<br> Redox Homeostasis Plays Important Roles in the Maintenance of the Drosophila Testis Germline Stem Cells.<br> Stem Cell Reports (2017) 9(1) 342-354
[
PubMed ID = 28669604
]
[
RRC reference
]
Hochmuth CE, Biteau B, Bohmann D, Jasper H.<br> Redox regulation by Keap1 and Nrf2 controls intestinal stem cell proliferation in Drosophila.<br> Cell Stem Cell (2011) 8(2) 188-99
[
PubMed ID = 21295275
]
[
RRC reference
]
Owusu-Ansah E, Banerjee U.<br> Reactive oxygen species prime Drosophila haematopoietic progenitors for differentiation.<br> Nature (2009) 461(7263) 537-41
[
PubMed ID = 19727075
]
[
RRC reference
]
|
| Comment |
|
| Sequence (Last Update: July 10, 2007_NCBI RefSeq Release 24) |
| Primer Seq. 5' |
aaggcctacatggccggaccgGGACCGCTAGTCAAGACCATC |
| Primer Seq. 3' |
aatctagaggtaccGCCTTAATGGCCTTGGCCACG |
| Predicted Fragment Size |
500 |
| IR fragment full Seq |
0001 GGACCGCTAG TCAAGACCAT CATGACACGC TGCATCCACT GCACCCGCTG TGTGCGTTTC
0061 GCCTCCGAGA TTGCCGGCGT TGATGACCTG GGCACCACTG GCCGTGGCAA CGACATGCAG
0121 ATCGGCACCT ACGTGGAGAA GCTCTTCCTT ACCGAACTGT CCGGCAACGT GATCGACCTG
0181 TGCCCCGTGG GAGCGCTGAC CAACAAGCCC TACAGTTTTG TGGCCCGTCC CTGGGAGATC
0241 CGTAAGGTGA GCAGCATCGA TGTGCTGGAC GCCGTCGGCA GCAACATTGT CGTCAGCACC
0301 CGCACCAATG AGGtGCTGCG CATCCTGCCC CGTGAGAACG AGGACGTCAA CGAGGAATGG
0361 CTTGCTGACA AATCGCGCTT CGCCTGCGAC GGTCTGAAGC GCCAgCNCCT GGTGGCTCCC
0421 ATGGTGCGCA TgNCCAACGG CGAACTACAG GCCGTAGAGT GGGAGGGTGC CCTCATCGCC
0481 GNGgcCAAGG CCATTAANGC |
| in silico PCR Fragment |
0001 GGACCGCTAG TCAAGACCAT CATGACACGC TGCATCCACT GCACCCGCTG TGTGCGTTTC
0061 GCCTCCGAGA TTGCCGGCGT TGATGACCTG GGCACCACTG GCCGTGGCAA CGACATGCAG
0121 ATCGGCACCT ACGTGGAGAA GCTCTTCCTT ACCGAACTGT CCGGCAACGT GATCGACCTG
0181 TGCCCCGTGG GAGCGCTGAC CAACAAGCCC TACAGTTTTG TGGCCCGTCC CTGGGAGATC
0241 CGTAAGGTGA GCAGCATCGA TGTGCTGGAC GCCGTCGGCA GCAACATTGT CGTCAGCACC
0301 CGCACCAATG AGGTGCTGCG CATCCTGCCC CGTGAGAACG AGGACGTCAA CGAGGAATGG
0361 CTTGCTGACA AATCGCGCTT CGCCTGCGAC GGTCTGAAGC GCCAGCGCCT GGTGGCTCCC
0421 ATGGTGCGCA TGCCCAACGG CGAACTACAG GCCGTAGAGT GGGAGGGTGC CCTCATCGCC
0481 GTGGCCAAGG CCATTAAGGC |
| Assemble Data |
<PRE>
2286R-2.IR_full 1 GGACCGCTAGTCAAGACCATCATGACACGCTGCATCCACTGCACCCGCTGTGTGCGTTTC 60
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2286R-2.in silico 1 GGACCGCTAGTCAAGACCATCATGACACGCTGCATCCACTGCACCCGCTGTGTGCGTTTC 60
2286R-2.IR_full 61 GCCTCCGAGATTGCCGGCGTTGATGACCTGGGCACCACTGGCCGTGGCAACGACATGCAG 120
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2286R-2.in silico 61 GCCTCCGAGATTGCCGGCGTTGATGACCTGGGCACCACTGGCCGTGGCAACGACATGCAG 120
2286R-2.IR_full 121 ATCGGCACCTACGTGGAGAAGCTCTTCCTTACCGAACTGTCCGGCAACGTGATCGACCTG 180
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2286R-2.in silico 121 ATCGGCACCTACGTGGAGAAGCTCTTCCTTACCGAACTGTCCGGCAACGTGATCGACCTG 180
2286R-2.IR_full 181 TGCCCCGTGGGAGCGCTGACCAACAAGCCCTACAGTTTTGTGGCCCGTCCCTGGGAGATC 240
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2286R-2.in silico 181 TGCCCCGTGGGAGCGCTGACCAACAAGCCCTACAGTTTTGTGGCCCGTCCCTGGGAGATC 240
2286R-2.IR_full 241 CGTAAGGTGAGCAGCATCGATGTGCTGGACGCCGTCGGCAGCAACATTGTCGTCAGCACC 300
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2286R-2.in silico 241 CGTAAGGTGAGCAGCATCGATGTGCTGGACGCCGTCGGCAGCAACATTGTCGTCAGCACC 300
2286R-2.IR_full 301 CGCACCAATGAGGTGCTGCGCATCCTGCCCCGTGAGAACGAGGACGTCAACGAGGAATGG 360
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2286R-2.in silico 301 CGCACCAATGAGGTGCTGCGCATCCTGCCCCGTGAGAACGAGGACGTCAACGAGGAATGG 360
2286R-2.IR_full 361 CTTGCTGACAAATCGCGCTTCGCCTGCGACGGTCTGAAGCGCCAGC<span class="snp"><tt>N</tt></span>CCTGGTGGCTCCC 420
||||||||||||||||||||||||||||||||||||||||||||||<span class="snp"><tt> </tt></span>|||||||||||||
2286R-2.in silico 361 CTTGCTGACAAATCGCGCTTCGCCTGCGACGGTCTGAAGCGCCAGC<span class="snp"><tt>G</tt></span>CCTGGTGGCTCCC 420
2286R-2.IR_full 421 ATGGTGCGCATG<span class="snp"><tt>N</tt></span>CCAACGGCGAACTACAGGCCGTAGAGTGGGAGGGTGCCCTCATCGCC 480
||||||||||||<span class="snp"><tt> </tt></span>|||||||||||||||||||||||||||||||||||||||||||||||
2286R-2.in silico 421 ATGGTGCGCATG<span class="snp"><tt>C</tt></span>CCAACGGCGAACTACAGGCCGTAGAGTGGGAGGGTGCCCTCATCGCC 480
2286R-2.IR_full 481 G<span class="snp"><tt>N</tt></span>GGCCAAGGCCATTAA<span class="snp"><tt>N</tt></span>GC 500
|<span class="snp"><tt> </tt></span>|||||||||||||||<span class="snp"><tt> </tt></span>||
2286R-2.in silico 481 G<span class="snp"><tt>T</tt></span>GGCCAAGGCCATTAA<span class="snp"><tt>G</tt></span>GC 500
</PRE>
|
| Off-target information (Last Update: November 4, 2007_NCBI RefSeq Release 26) |
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
| cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
| 100 |
482 |
0 |
0 |
0 |
NM_167152.1 |
CG2286-RB, transcript variant B (ND75), mRNA |
| 100 |
482 |
0 |
0 |
0 |
NM_078528.1 |
CG2286-RA, transcript variant A (ND75), mRNA |
| 0 |
0 |
3 |
2 |
10 |
NM_143367.2 |
CG10011-RA (CG10011), mRNA |
| 0 |
0 |
3 |
2 |
3 |
NM_131946.3 |
CG12184-RA (CG12184), mRNA |
| 0 |
0 |
2 |
5 |
3 |
NM_170168.1 |
CG6863-RB, transcript variant B (tok), mRNA |
| 0 |
0 |
2 |
5 |
3 |
NM_057531.3 |
CG6863-RA, transcript variant A (tok), mRNA |
| 0 |
0 |
2 |
4 |
2 |
NM_079311.2 |
CG5638-RA (Rh7), mRNA |
| 0 |
0 |
2 |
2 |
12 |
NM_143018.2 |
CG5794-RD, transcript variant D (CG5794), mRNA |
| 0 |
0 |
2 |
2 |
12 |
NM_170158.1 |
CG5794-RB, transcript variant B (CG5794), mRNA |
| 0 |
0 |
2 |
2 |
10 |
NM_206564.1 |
CG5794-RE, transcript variant E (CG5794), mRNA |
| 0 |
0 |
2 |
2 |
3 |
NM_001014494.1 |
CG33509-RA (CG33509), mRNA |
| 0 |
0 |
2 |
2 |
2 |
NM_079188.1 |
CG1132-RA (fd64A), mRNA |
| 0 |
0 |
1 |
6 |
3 |
NM_134655.1 |
CG11620-RA (CG11620), mRNA |
| 0 |
0 |
1 |
5 |
9 |
NM_176232.1 |
CG15097-RB, transcript variant B (CG15097), mRNA |
| 0 |
0 |
1 |
5 |
9 |
NM_137533.3 |
CG15097-RA, transcript variant A (CG15097), mRNA |
| 0 |
0 |
1 |
4 |
2 |
NM_169966.1 |
CG31198-RA (CG31198), mRNA |
| 0 |
0 |
1 |
3 |
5 |
NM_136907.1 |
CG13169-RA (CG13169), mRNA |
| 0 |
0 |
1 |
3 |
3 |
NM_132437.1 |
CG15207-RA (CG15207), mRNA |
| 0 |
0 |
1 |
3 |
3 |
NM_137822.2 |
CG13506-RA (CG13506), mRNA |
| 0 |
0 |
1 |
2 |
5 |
NM_078726.2 |
CG4385-RB, transcript variant B (S), mRNA |
| 0 |
0 |
1 |
2 |
4 |
NM_135895.2 |
CG15269-RA (CG15269), mRNA |
| 0 |
0 |
1 |
2 |
4 |
NM_167618.1 |
CG32551-RA (CG32551), mRNA |
| 0 |
0 |
1 |
2 |
2 |
NM_141084.2 |
CG7162-RA (MED1), mRNA |
| 0 |
0 |
1 |
2 |
2 |
NM_141681.1 |
CG9475-RA, transcript variant A (Rpt3R), mRNA |
| 0 |
0 |
1 |
2 |
2 |
NM_169308.2 |
CG9475-RB, transcript variant B (Rpt3R), mRNA |
| 0 |
0 |
0 |
7 |
8 |
NM_168547.1 |
CG10738-RA, transcript variant A (CG10738), mRNA |
| 0 |
0 |
0 |
7 |
8 |
NM_140396.1 |
CG10738-RB, transcript variant B (CG10738), mRNA |
| 0 |
0 |
0 |
7 |
4 |
NM_132053.1 |
CG6041-RA (CG6041), mRNA |
| 0 |
0 |
0 |
7 |
3 |
NM_079917.2 |
CG18296-RA (axo), mRNA |
| 0 |
0 |
0 |
6 |
2 |
NM_143026.1 |
CG6879-RA (CG6879), mRNA |
|
|
Pathways (updated: 2024/04/26)
|
| KEGG Pathway |
dme00190
:
Oxidative phosphorylation
dme01100
:
Metabolic pathways
|
|
|
